NASDAQ:JAGX • US47010C8881
Past quarterly earnings results for JAGUAR HEALTH INC (JAGX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -6.28 | -5.18 | -21.20% | 76.08% | 3.083M | 3.805M | -18.98% | -0.80% |
| Q2 2025 | -10.26 | -7.27 | -41.08% | 89.84% | 2.936M | 3.33M | -11.83% | 7.90% |
| Q1 2025 | -16.70 | -18.36 | 9.04% | 84.10% | 2.214M | 2.877M | -23.04% | -5.83% |
| Q4 2024 | -0.34 | -18.87 | 98.20% | 65.99% | 3.465M | 3.193M | 8.52% | 50.65% |
| Q3 2024 | -26.25 | -60.44 | 56.56% | 96.82% | 3.108M | 4.017M | -22.63% | 10.49% |
| Q2 2024 | -101.00 | -30.60 | -230.07% | 90.24% | 2.721M | 3.494M | -22.12% | 1.68% |
| Q1 2024 | -105.00 | -45.90 | -128.76% | -171,468.63% | 2.351M | 3.017M | -22.07% | 19.22% |
| Q4 2023 | -1.00 | - | 89.95% | 2.3M | 2.662M | -13.60% | -29.45% | |
| Q3 2023 | -825.00 | -1,881.90 | 56.16% | 93.89% | 2.813M | 2.509M | 12.12% | -10.70% |
| Q2 2023 | -1,035.00 | -2,340.90 | 55.79% | 92.33% | 2.676M | 2.326M | 15.05% | -8.39% |
| Q1 2023 | -0.06 | - | 100.00% | 1.972M | 3.978M | -50.43% | -24.88% | |
| Q4 2022 | -9.95 | - | 99.97% | 3.26M | 2.04M | 59.80% | 56.73% | |
| Q3 2022 | -13,500.00 | -8,606.25 | -56.86% | 55.56% | 3.15M | 3.621M | -13.01% | 400.00% |
| Q2 2022 | -13,500.00 | -25,245.00 | 46.52% | 60.00% | 2.921M | 3.162M | -7.62% | 658.70% |
| Q1 2022 | -45,000.00 | -20,081.25 | -124.09% | -33.33% | 2.625M | 1.652M | 58.90% | 111.52% |
| Q4 2021 | -34,875.00 | -10,327.50 | -237.69% | 31.11% | 2.08M | 8.548M | -75.67% | -19.25% |
| Q3 2021 | -30,375.00 | -20,081.25 | -51.26% | 57.14% | 630K | 2.683M | -76.52% | -77.28% |
| Q2 2021 | -33,750.00 | -13,770.00 | -145.10% | 65.52% | 385K | 5.049M | -92.37% | -87.84% |
| Q1 2021 | -33,750.00 | -6,885.00 | -390.20% | 77.78% | 1.241M | 7.548M | -83.56% | 42.81% |
| Q4 2020 | -50,625.00 | -34,425.00 | -47.06% | - | 2.576M | 2.346M | 9.80% | - |
| Q3 2020 | -70,875.00 | -37,867.50 | -87.17% | - | 2.773M | 7.956M | -65.15% | - |
| Q2 2020 | -97,875.00 | -51,637.50 | -89.54% | - | 3.167M | 4.874M | -35.02% | - |
| Q1 2020 | -151,875.00 | -79,177.50 | -91.82% | - | 869K | 2.545M | -65.85% | - |
Notes
JAGUAR HEALTH INC (JAGX) last reported earnings on 11/18/2025.
JAGUAR HEALTH INC (JAGX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, JAGUAR HEALTH INC (JAGX) has beaten EPS estimates in 2 out of 4 releases.